Analyst at Morgan Stanley weighed in Moderna (NASDAQ: MRNA) RNA-based experimental seasonal flu vaccine and called it undifferentiated versus Fluzone ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA Trader Talk

Moderna's (MRNA) COVID-19 Vaccine Manufactured in Korea by Samsung Granted Marketing Authorization from Ministry of Food and Drug Safety of KoreaDecember 14, 2021 5:46 AM Moderna (MRNA) Continues to Grind off Lows, Remains Down 5.5%December 10, 2021 12:14 PM